Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population.
Ahmadzada T, Cooper WA, Holmes M, Mahar A, Westman H, Gill AJ, Nordman I, Yip PY, Pal A, Zielinski R, Pavlakis N, Nagrial A, Daneshvar D, Brungs D, Karikios D, Aleksova V, Burn J, Asher R, Grau GE, Hosseini-Beheshti E, Reid G, Clarke S, Kao S.
Ahmadzada T, et al. Among authors: westman h.
JTO Clin Res Rep. 2020 Jul 16;1(4):100075. doi: 10.1016/j.jtocrr.2020.100075. eCollection 2020 Nov.
JTO Clin Res Rep. 2020.
PMID: 34589956
Free PMC article.